15 completed. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 15 |
Follow Growth Hormone Deficiency: new trials by email Literature Review of Growth Hormone Deficiency trials Research Report on Growth Hormone Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency Somatropin - Growth Hormone Deficiency | Phase 4 | Completed | Genentech, Inc. | 82 | 2015-03-31 | 2019-01-08 |
| GH and Cardiovascular Risk Factors Change in daily dosage of Growth Hormone - Growth Hormone Deficiency, Cardiovascular Diseases | Phase 4 | Completed | Amsterdam UMC, location VUmc | 32 | 2013-05-01 | 2014-05-07 |
| Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) sustained-release recombinant human GH (SR-rhGH) - Growth Hormone Deficiency | Phase 4 | Completed | LG Life Sciences | 132 | 2009-12-01 | 2012-10-05 |
| Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method T-jet® containing TevTropin®, TevTropin® needle-syringe injection method - Growth Hormone Deficiency | Phase 4 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 52 | 2009-09-01 | 2011-07-25 |
| Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? Growth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests, H.G.P.O, osseous age., biopsy - Prader-Willi Syndrome, Growth Hormone Deficiency | Phase 4 | Completed | University Hospital, Toulouse | 111 | 2009-01-01 | 2021-09-24 |
| Easypod United States User Trial easypod - Growth Hormone Deficiency | Phase 4 | Completed | EMD Serono | 42 | 2008-03-01 | 2015-05-15 |
| Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® Saizen - Growth Hormone Deficiency, Turner Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 318 | 2005-05-31 | 2018-06-26 |
| Growth Hormone and Endothelial Function in Children growth hormone - Growth Hormone Deficiency, Panhypopituitarism | Phase 4 | Completed | Ohio State University | 9 | 2005-01-01 | 2018-05-30 |
| A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood Nutropin AQ - Kidney Failure, Chronic, Growth Hormone Deficiency | Phase 4 | Completed | Oregon Health and Science University | 17 | 2005-01-01 | 2011-10-26 |
| Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia Nutropin AQ - Growth Hormone Deficiency, Septo-Optic Dysplasia | Phase 4 | Completed | Children's Hospital Los Angeles | 20 | 2004-12-01 | 2015-04-01 |
| Growth Hormone and Glucose Metabolism recombinant human Growth Hormone (Genotropin® ) - Growth Hormone Deficiency | Phase 4 | Completed | Charite University, Berlin, Germany | 6 | 2003-11-01 | 2009-06-30 |
| Anterior Pituitary Hormone Replacement in Traumatic Brain Injury Recombinant human growth hormone - Growth Hormone Deficiency, Traumatic Brain Injury | Phase 4 | Completed | The University of Texas Medical Branch, Galveston | 15 | 2003-11-01 | 2018-06-29 |
| A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood r-hGH - Dwarfism, Growth Hormone Deficiency | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 34 | 2003-09-01 | 2014-07-11 |
| IGF1 Generation Test Blood sample, Radiography - Growth Hormone Deficiency | Phase 4 | Completed | Pfizer | 82 | 2001-04-01 | 2007-06-06 |
Dwarfism, Pituitary (15) · Dwarfism (4) · Kidney Failure, Chronic (2) · Turner Syndrome (2) · Brain Injuries, Traumatic (1) · Cardiovascular Diseases (1) · Combined Pituitary Hormone Deficiency (1) · Hypopituitarism (1) · Metabolic Syndrome (1) · Motor Activity (1) · Optic Nerve Hypoplasia (1) · Prader-Willi Syndrome (1) · Septo-Optic Dysplasia (1)
Bone Diseases (15) · Bone Diseases, Developmental (15) · Bone Diseases, Endocrine (15) · Brain Diseases (15) · Central Nervous System Diseases (15) · Endocrine System Diseases (15) · Hypothalamic Diseases (15) · Musculoskeletal Diseases (15) · Nervous System Diseases (15) · Pituitary Diseases (15) · Hypopituitarism (14) · Dwarfism (11) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Genetic Diseases, Inborn (7) · Congenital Abnormalities (4)
Human Growth Hormone (7) · Growth Hormone (6) · Absorptiometry, Photon (1) · Biopsy (1) · Blood Specimen Collection (1) · Hematologic Tests (1) · X-Rays (1)
LG Life Sciences (2) · Merck KGaA, Darmstadt, Germany (2) · Amsterdam UMC, location VUmc (1) · Charite University, Berlin, Germany (1) · Children's Hospital Los Angeles (1) · EMD Serono (1) · Genentech, Inc. (1) · Ohio State University (1) · Oregon Health and Science University (1) · Pfizer (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital, Toulouse (1)
United States (6) · France (3) · Germany (2) · Argentina (1) · Australia (1) · Austria (1) · Canada (1) · Italy (1) · Netherlands (1) · Norway (1) · Russia (1) · Singapore (1) · South Korea (1) · Spain (1) · Sweden (1)
Amira Y Al-Uzri, M.D. (1) · Ayman M Arafat, Dr.med. (1) · Madeleine L. Drent, MD PhD (1) · Mark Borchert, MD (1) · Mitchell Geffner, MD (1) · Randall J Urban, M.D. (1) · Robert P Hoffman, MD (1) · Theodor Wee, MD (1) · Thomas Smith, MD (1)
PMID 20372873, PMID 23567489, PMID 24013497, PMID 24406482, PMID 24916642, PMID 26340968, PMID 29618660, PMID 29980224, PMID 31908426, PMID 33633687, PMID 34040195, PMID 34045667, PMID 38561465